|
GB9823103D0
(en)
*
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
WO2002009713A2
(de)
*
|
2000-08-01 |
2002-02-07 |
Bayer Aktiengesellschaft |
Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
|
|
EP1343506A1
(de)
*
|
2000-12-19 |
2003-09-17 |
MERCK PATENT GmbH |
Pharmazeutische formulierung enthaltend pyrazolo 4,3-d]pyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
|
|
DE10064105A1
(de)
|
2000-12-21 |
2002-06-27 |
Bayer Ag |
Neue Substituierte Imidazotriazinone
|
|
JP2004525890A
(ja)
*
|
2001-02-02 |
2004-08-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
ピラゾロ［４，３−ｄ］ピリミジンおよびエンドセリンレセプターアンタゴニストまたはチエノピリミジンおよびエンドセリンレセプターアンタゴニストを含む医薬製剤
|
|
KR100393160B1
(ko)
*
|
2001-06-14 |
2003-07-31 |
한국과학기술연구원 |
신규한 피라졸로피리미딘티온 유도체, 그의 제법 및발기부전 치료제로서의 용도
|
|
US6479493B1
(en)
|
2001-08-23 |
2002-11-12 |
Cell Pathways, Inc. |
Methods for treatment of type I diabetes
|
|
AU2002366440A1
(en)
*
|
2001-09-27 |
2003-09-09 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
FR2842809A1
(fr)
*
|
2002-07-26 |
2004-01-30 |
Greenpharma Sas |
NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
|
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
|
DE10238723A1
(de)
*
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
CN100397023C
(zh)
*
|
2003-01-04 |
2008-06-25 |
胡云北 |
黄磷废渣载热量及反应尾气发热量的回收与综合利用方法
|
|
EP1601675A1
(en)
*
|
2003-03-04 |
2005-12-07 |
ALTANA Pharma AG |
Purin-6-one-derivatives
|
|
DE102004004142A1
(de)
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
|
|
DE10320785A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
|
US8044060B2
(en)
|
2003-05-09 |
2011-10-25 |
Boehringer Ingelheim International Gmbh |
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
|
|
DE10328479A1
(de)
|
2003-06-25 |
2005-01-13 |
Bayer Ag |
6-Arylamino-5-cyano-4-pyrimidinone
|
|
AU2004268387A1
(en)
*
|
2003-08-28 |
2005-03-10 |
Nycomed Gmbh |
Composition comprising a pulmonary surfactant and a PDE2 inhibitor
|
|
DE102004001873A1
(de)
*
|
2004-01-14 |
2005-09-29 |
Bayer Healthcare Ag |
Cyanopyrimidinone
|
|
AU2005219517A1
(en)
*
|
2004-02-27 |
2005-09-15 |
F.Hoffmann-La Roche Ag |
Heteroaryl-fused pyrazolo derivatives
|
|
CN101397299B
(zh)
*
|
2007-09-29 |
2011-11-16 |
温州大学 |
一种吡唑[3,4-d]嘧啶酮的合成方法
|
|
JP5498392B2
(ja)
|
2007-11-30 |
2014-05-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１，５−ジヒドロ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体及びｃｎｓ障害の治療のためのｐｄｅ９ａモジュレーターとしてのそれらの使用
|
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
|
JP5453431B2
(ja)
|
2008-09-08 |
2014-03-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピラゾロピリミジン及びｃｎｓ障害の治療のためのそれらの使用
|
|
CA2756870A1
(en)
|
2009-03-31 |
2010-10-07 |
Arqule, Inc. |
Substituted indolo-pyridinone compounds
|
|
PE20120505A1
(es)
|
2009-03-31 |
2012-05-09 |
Boehringer Ingelheim Int |
Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
|
|
AR077859A1
(es)
*
|
2009-08-12 |
2011-09-28 |
Boehringer Ingelheim Int |
Compuestos para el tratamiento de trastornos del snc
|
|
AP2012006631A0
(en)
|
2010-08-12 |
2012-12-31 |
Boehringer Ingelheim Int |
6-Cycloalkyl-1, 5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A inhibitors
|
|
US20130040971A1
(en)
|
2011-02-14 |
2013-02-14 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
EP2691393B1
(en)
|
2011-03-31 |
2016-09-14 |
Pfizer Inc |
Novel bicyclic pyridinones
|
|
WO2012172449A1
(en)
|
2011-06-13 |
2012-12-20 |
Pfizer Inc. |
Lactams as beta secretase inhibitors
|
|
ES2605565T3
(es)
|
2011-08-31 |
2017-03-15 |
Pfizer Inc |
Compuestos de hexahidropirano [3,4-D][1,3]tiazin-2-amina
|
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
CN105121439A
(zh)
|
2013-02-19 |
2015-12-02 |
辉瑞公司 |
作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
|
|
ES2742078T3
(es)
|
2013-10-04 |
2020-02-13 |
Pfizer |
Piridonas bicíclicas novedosas como moduladores de gamma-secretasa
|
|
DK3126361T3
(da)
|
2014-04-01 |
2020-01-02 |
Pfizer |
Chromen og 1,1a,2,7b-tetrahydrocyclopropa[c]chromen- pyridopyrazindioner som gamma-sekretase-modulatorer
|
|
WO2016012896A1
(en)
|
2014-07-24 |
2016-01-28 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
|
PL3177624T3
(pl)
|
2014-08-06 |
2019-09-30 |
Pfizer Inc. |
Związki imidazopirydazynowe
|
|
MX368391B
(es)
|
2015-02-03 |
2019-09-30 |
Pfizer |
Ciclopropabenzofuranil-piridopirazindionas novedosas.
|
|
JO3627B1
(ar)
|
2015-04-30 |
2020-08-27 |
H Lundbeck As |
إيميدازو بيرازينونات على هيئة مثبطات pde1
|
|
WO2016179059A1
(en)
*
|
2015-05-05 |
2016-11-10 |
Merck Sharp & Dohme Corp. |
Heteroaryl-pyrimidinone compounds as pde2 inhibitors
|
|
EP3766885B1
(en)
|
2015-06-17 |
2022-05-25 |
Pfizer Inc. |
Tricyclic compounds and their use as phosphodiesterase inhibitors
|
|
SG11201806383TA
(en)
|
2016-02-23 |
2018-09-27 |
Pfizer |
6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
|
|
TWI729109B
(zh)
|
2016-04-12 |
2021-06-01 |
丹麥商Ｈ 朗德貝克公司 |
作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
|
|
WO2018002760A1
(en)
|
2016-07-01 |
2018-01-04 |
Pfizer Inc. |
5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases
|
|
ES2967489T3
(es)
*
|
2016-10-18 |
2024-04-30 |
H Lundbeck As |
Imidazopirazinonas, pirazolopirimidinonas y pirazolopiridinonas como inhibidores de PDE1
|
|
MX2019004859A
(es)
|
2016-10-28 |
2019-06-20 |
H Lundbeck As |
Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas.
|
|
RU2019109039A
(ru)
|
2016-10-28 |
2020-11-30 |
Х. Лундбекк А/С |
Комбинированные средства для лечения, предусматривающего введение имидазопиразинонов, предназначенные для лечения психических и/или когнитивных расстройств
|
|
JP7111720B2
(ja)
|
2016-12-28 |
2022-08-02 |
ダート・ニューロサイエンス・エルエルシー |
Ｐｄｅ２阻害剤としての置換ピラゾロピリミジノン化合物
|
|
RU2019144010A
(ru)
|
2017-06-08 |
2021-07-13 |
Мерк Шарп И Доум Корп. |
Пиразолопиримидиновые ингибиторы pde9
|
|
BR112019026955A2
(pt)
|
2017-06-22 |
2020-06-30 |
Pfizer Inc. |
derivados de di-hidro-pirrolo-piridina
|
|
CA3120971A1
(en)
|
2017-11-27 |
2019-05-31 |
Dart Neuroscience, Llc |
Substituted furanopyrimidine compounds as pde1 inhibitors
|
|
EP4219464A1
(en)
|
2018-03-23 |
2023-08-02 |
Pfizer Inc. |
Piperazine azaspiro derivaves
|
|
USD1029414S1
(en)
*
|
2021-01-19 |
2024-05-28 |
Averia Electronics, Inc. |
Wearable light emitting module with a removable band
|
|
USD1021287S1
(en)
*
|
2021-01-19 |
2024-04-02 |
Averia Electronics, Inc. |
Wearable light emitting module with a removable band
|
|
EP4297868A4
(en)
|
2021-02-23 |
2025-01-08 |
Hoth Therapeutics, Inc. |
USE OF APREPITANT TO TREAT ALZHEIMER'S
|
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
|
WO2025145091A1
(en)
|
2023-12-29 |
2025-07-03 |
Pfizer Inc. |
Crystalline forms of a muscarinic m4 receptor modulator and methods of treating diseases
|